Analysts’ Weekly Ratings Changes for McKesson (MCK)

McKesson (NYSE: MCK) has recently received a number of price target changes and ratings updates:

• 3/22/2026 – McKesson was upgraded by Wall Street Zen from “hold” to “buy”.
• 3/14/2026 – McKesson was downgraded by Wall Street Zen from “buy” to “hold”.
• 3/5/2026 – McKesson was given a new $970.00 price target by Raymond James Financial, Inc..
• 3/5/2026 – McKesson had its “outperform” rating reaffirmed by Leerink Partners. They now have a $1,085.00 price target on the stock.
• 3/5/2026 – McKesson had its “outperform” rating reaffirmed by Evercore Inc.
• 2/18/2026 – McKesson had its price target raised by Barclays PLC from $960.00 to $1,050.00. They now have an “overweight” rating on the stock.
• 2/10/2026 – McKesson had its price target raised by JPMorgan Chase & Co. from $983.00 to $1,107.00. They now have an “overweight” rating on the stock.
• 2/5/2026 – McKesson was downgraded by Weiss Ratings from “buy (a-)” to “buy (b+)”.
• 2/5/2026 – McKesson had its price target raised by TD Cowen from $1,000.00 to $1,012.00. They now have a “buy” rating on the stock.
• 2/5/2026 – McKesson had its price target raised by Wells Fargo & Company from $914.00 to $925.00. They now have an “equal weight” rating on the stock.
• 2/5/2026 – McKesson had its price target raised by Mizuho from $880.00 to $885.00. They now have a “neutral” rating on the stock.
• 1/29/2026 – McKesson had its “overweight” rating reaffirmed by Morgan Stanley. They now have a $966.00 price target on the stock.

McKesson Dividend Announcement

The firm also recently declared a quarterly dividend, which will be paid on Wednesday, April 1st. Investors of record on Monday, March 2nd will be paid a $0.82 dividend. This represents a $3.28 annualized dividend and a dividend yield of 0.4%. The ex-dividend date is Monday, March 2nd. McKesson’s dividend payout ratio (DPR) is presently 9.43%.

Insider Activity at McKesson

In other McKesson news, CAO Napoleon B. Rutledge, Jr. sold 328 shares of the firm’s stock in a transaction that occurred on Friday, February 6th. The shares were sold at an average price of $955.00, for a total transaction of $313,240.00. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available at this link. Also, EVP Michele Lau sold 2,725 shares of the business’s stock in a transaction that occurred on Monday, March 2nd. The stock was sold at an average price of $990.00, for a total value of $2,697,750.00. Following the completion of the sale, the executive vice president directly owned 3,247 shares in the company, valued at approximately $3,214,530. This represents a 45.63% decrease in their ownership of the stock. The SEC filing for this sale provides additional information. Insiders sold a total of 3,868 shares of company stock worth $3,743,820 over the last 90 days. 0.08% of the stock is currently owned by insiders.

McKesson Corporation (NYSE: MCK) is a global healthcare services and distribution company that supplies pharmaceuticals, medical-surgical products and health care technology solutions. Founded in 1833 and headquartered in Irving, Texas, McKesson operates across the drug distribution and healthcare services value chain, connecting manufacturers, pharmacies, hospitals and health systems to help manage the movement of medicines and clinical supplies.

The company’s core activities include pharmaceutical wholesale distribution and logistics, specialty pharmacy services, and the provision of medical-surgical supplies to acute and non-acute care providers.